Tri-anim signs specialty distribution agreement with Premier
Dale Clendon, vice president of sales and marketing of Tri-anim, said: “We are very proud to be chosen once more by Premier as a specialty distributor. This agreement
Ionis Pharmaceuticals has entered a licence agreement granting global pharmaceutical company Recordati exclusive rights to develop and commercialise zilganersen to treat Alexander disease (AxD) in countries outside the US.